Search

Your search keyword '"Lewerenz, J"' showing total 74 results

Search Constraints

Start Over You searched for: Author "Lewerenz, J" Remove constraint Author: "Lewerenz, J" Search Limiters Full Text Remove constraint Search Limiters: Full Text
74 results on '"Lewerenz, J"'

Search Results

1. S1 guidelines “lumbar puncture and cerebrospinal fluid analysis” (abridged and translated version)

2. Identification of symbol digit modality test score extremes in Huntington's disease

4. Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature

5. Suicidal ideation in a European Huntington's disease population

6. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

7. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

8. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

9. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

10. Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis

17. Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression.

18. Dementia and leukoencephalopathy due to lymphomatosis cerebri.

19. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study

20. Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis.

21. HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease.

22. Development of an algorithm for identifying paraneoplastic ischemic stroke in association with lung, pancreatic, and colorectal cancer.

23. Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 Antibodies.

24. Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases - a retrospective cross-sectional study.

25. Translational imaging of TSPO reveals pronounced innate inflammation in human and murine CD8 T cell-mediated limbic encephalitis.

26. CSF oligoclonal IgG bands are not associated with ALS progression and prognosis.

27. A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.

28. Antibodies Against Glutamic Acid Decarboxylase 65 Are Locally Produced in the CSF and Arise During Affinity Maturation.

29. Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis.

30. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.

31. Study protocol of IMAGINE-HD: Imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington's disease.

32. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.

33. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.

34. CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.

35. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.

36. Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis.

37. Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis.

38. Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS Infections.

39. A 64-Year-Old Patient With a Mesiotemporal Mass and Symptomatic Epilepsy.

40. Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington's disease patients.

41. Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis.

42. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.

43. Genotypes and phenotypes of patients with Lafora disease living in Germany.

44. On Razor's edge: Managing analgosedation during severe anti-NMDA receptor encephalitis.

45. Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment.

46. Oxytosis/Ferroptosis-(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System.

47. Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature.

48. Absence of system x c - on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.

49. Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β.

50. Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?

Catalog

Books, media, physical & digital resources